top of page
Accessible | Afforable | Innovation
Our CAR-T Cell Therapies are avialable at major cancer hospitals across India
We are committed to connecting patients, caregivers, and healthcare providers in the cell therapy community to the centers where our therapies are accessible.
Partner Hospitals are provided below by regional zones in India.
APPROVED USE
NexCAR19 is commercially approved in India for the treatment of B-lymphomas and B-Acute Lymphoblastic Leukaemia where one or more lines of treatment have failed or have been rendered inadequate or insufficient to render a response.
bottom of page